Header Logo

Connection

David Bennett to Apolipoproteins E

Back to Details
This is a "connection" page, showing publications David Bennett has written about Apolipoproteins E.
David Bennett
Connection Strength
7.666
Apolipoproteins E
  1. Association of APOE with tau-tangle pathology with and without ?-amyloid. Neurobiol Aging. 2016 Jan; 37:19-25.
    View in: PubMed
    Score: 0.457
  2. Dementia: Cognitive resilience in APOE*e4 carriers?is race important? Nat Rev Neurol. 2015 Apr; 11(4):190-1.
    View in: PubMed
    Score: 0.441
  3. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol Aging. 2014 Apr; 35(4):819-26.
    View in: PubMed
    Score: 0.399
  4. APOE e4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death. Psychol Aging. 2013 Dec; 28(4):1015-23.
    View in: PubMed
    Score: 0.387
  5. Amyloid pathology in persons with "normal" cognition. Neurology. 2012 Jan 24; 78(4):228-9.
    View in: PubMed
    Score: 0.352
  6. Heritability of different forms of memory in the Late Onset Alzheimer's Disease Family Study. J Alzheimers Dis. 2011; 23(2):249-55.
    View in: PubMed
    Score: 0.329
  7. Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles. Neurology. 2009 Apr 28; 72(17):1495-503.
    View in: PubMed
    Score: 0.293
  8. Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people. J Neurol Neurosurg Psychiatry. 2005 Sep; 76(9):1194-9.
    View in: PubMed
    Score: 0.227
  9. The apolipoprotein E epsilon4 allele increases the odds of chronic cerebral infarction [corrected] detected at autopsy in older persons. Stroke. 2005 May; 36(5):954-9.
    View in: PubMed
    Score: 0.220
  10. The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment. Neurocase. 2005 Feb; 11(1):3-7.
    View in: PubMed
    Score: 0.218
  11. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology. 2003 Jan 28; 60(2):246-52.
    View in: PubMed
    Score: 0.190
  12. The apolipoprotein E epsilon 2 allele and decline in episodic memory. J Neurol Neurosurg Psychiatry. 2002 Dec; 73(6):672-7.
    View in: PubMed
    Score: 0.188
  13. The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol. 2002 Jul; 59(7):1154-60.
    View in: PubMed
    Score: 0.182
  14. Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Mol Neurodegener. 2022 06 15; 17(1):42.
    View in: PubMed
    Score: 0.182
  15. Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer's disease. Nat Neurosci. 2021 06; 24(6):786-798.
    View in: PubMed
    Score: 0.168
  16. TOMM40-APOE haplotypes are associated with cognitive decline in non-demented Blacks. Alzheimers Dement. 2021 08; 17(8):1287-1296.
    View in: PubMed
    Score: 0.166
  17. Extending Alzheimer disease biomarker studies into the Hispanic community. Neurology. 2020 10 13; 95(15):665-666.
    View in: PubMed
    Score: 0.161
  18. Sex and APOE e4 genotype modify the Alzheimer's disease serum metabolome. Nat Commun. 2020 03 02; 11(1):1148.
    View in: PubMed
    Score: 0.155
  19. Episodic memory performance in a multi-ethnic longitudinal study of 13,037 elderly. PLoS One. 2018; 13(11):e0206803.
    View in: PubMed
    Score: 0.142
  20. APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults. Alzheimers Dement. 2019 02; 15(2):258-266.
    View in: PubMed
    Score: 0.141
  21. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol. 2018 08 01; 75(8):989-998.
    View in: PubMed
    Score: 0.139
  22. Neuropathologic features of TOMM40 '523 variant on late-life cognitive decline. Alzheimers Dement. 2017 Dec; 13(12):1380-1388.
    View in: PubMed
    Score: 0.129
  23. Polygenic risk scores in familial Alzheimer disease. Neurology. 2017 Mar 21; 88(12):1180-1186.
    View in: PubMed
    Score: 0.126
  24. Relation of genomic variants for Alzheimer disease dementia to common neuropathologies. Neurology. 2016 Aug 02; 87(5):489-96.
    View in: PubMed
    Score: 0.120
  25. Association of DNA methylation in the brain with age in older persons is confounded by common neuropathologies. Int J Biochem Cell Biol. 2015 Oct; 67:58-64.
    View in: PubMed
    Score: 0.111
  26. GWAS of longevity in CHARGE consortium confirms APOE and FOXO3 candidacy. J Gerontol A Biol Sci Med Sci. 2015 Jan; 70(1):110-8.
    View in: PubMed
    Score: 0.106
  27. A 2-process model for neuropathology of Alzheimer's disease. Neurobiol Aging. 2014 Feb; 35(2):301-8.
    View in: PubMed
    Score: 0.099
  28. A random change point model for cognitive decline in Alzheimer's disease and mild cognitive impairment. Neuroepidemiology. 2012; 39(2):73-83.
    View in: PubMed
    Score: 0.092
  29. Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet. 2011 Feb; 7(2):e1001308.
    View in: PubMed
    Score: 0.083
  30. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol. 2010 Dec; 67(12):1473-84.
    View in: PubMed
    Score: 0.080
  31. Relation of blood pressure to risk of incident Alzheimer's disease and change in global cognitive function in older persons. Neuroepidemiology. 2006; 26(1):30-6.
    View in: PubMed
    Score: 0.057
  32. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 2005 Jun; 62(6):685-91.
    View in: PubMed
    Score: 0.056
  33. Assessment of cognitive decline in old age with brief tests amenable to telephone administration. Neuroepidemiology. 2005; 25(1):19-25.
    View in: PubMed
    Score: 0.054
  34. Associations of Sex, Race, and Apolipoprotein E Alleles With Multiple Domains of Cognition Among Older Adults. JAMA Neurol. 2023 09 01; 80(9):929-939.
    View in: PubMed
    Score: 0.049
  35. Parkinsonianlike signs and risk of incident Alzheimer disease in older persons. Arch Neurol. 2003 Apr; 60(4):539-44.
    View in: PubMed
    Score: 0.048
  36. Association of Mediterranean-DASH Intervention for Neurodegenerative Delay and Mediterranean Diets With Alzheimer Disease Pathology. Neurology. 2023 05 30; 100(22):e2259-e2268.
    View in: PubMed
    Score: 0.048
  37. Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol. 2003 Feb; 60(2):185-9.
    View in: PubMed
    Score: 0.048
  38. Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer's dementia. Alzheimers Res Ther. 2022 10 11; 14(1):152.
    View in: PubMed
    Score: 0.047
  39. APOE e4 and Alzheimer's disease diagnosis associated differences in L-carnitine, GBB, TMAO, and acylcarnitines in blood and brain. Curr Res Transl Med. 2023 Jan-Mar; 71(1):103362.
    View in: PubMed
    Score: 0.046
  40. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA. 2002 Feb 13; 287(6):742-8.
    View in: PubMed
    Score: 0.044
  41. Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease. Alzheimers Res Ther. 2022 02 09; 14(1):30.
    View in: PubMed
    Score: 0.044
  42. Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ?2 for Alzheimer's disease. Alzheimers Dement. 2022 11; 18(11):2042-2054.
    View in: PubMed
    Score: 0.044
  43. The National Institute on Aging Late-Onset Alzheimer's Disease Family Based Study: A resource for genetic discovery. Alzheimers Dement. 2022 10; 18(10):1889-1897.
    View in: PubMed
    Score: 0.044
  44. Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study. J Alzheimers Dis. 2022; 88(2):653-661.
    View in: PubMed
    Score: 0.044
  45. Integration of GWAS and brain transcriptomic analyses in a multiethnic sample of 35,245 older adults identifies DCDC2 gene as predictor of episodic memory maintenance. Alzheimers Dement. 2022 10; 18(10):1797-1811.
    View in: PubMed
    Score: 0.044
  46. Epigenomic features related to microglia are associated with attenuated effect of APOE e4 on Alzheimer's disease risk in humans. Alzheimers Dement. 2022 04; 18(4):688-699.
    View in: PubMed
    Score: 0.043
  47. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer's disease pathogenesis. Nat Genet. 2021 02; 53(2):143-146.
    View in: PubMed
    Score: 0.041
  48. Part I. Epidemiology and public health impact of Alzheimer's disease. Dis Mon. 2000 Oct; 46(10):657-65.
    View in: PubMed
    Score: 0.040
  49. Genetics of Gene Expression in the Aging Human Brain Reveal TDP-43 Proteinopathy Pathophysiology. Neuron. 2020 08 05; 107(3):496-508.e6.
    View in: PubMed
    Score: 0.040
  50. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease. Acta Neuropathol. 2019 05; 137(5):801-823.
    View in: PubMed
    Score: 0.036
  51. Neuropathological correlates and genetic architecture of microglial activation in elderly human brain. Nat Commun. 2019 01 24; 10(1):409.
    View in: PubMed
    Score: 0.036
  52. Subtypes Based on Neuropsychological Performance Predict Incident Dementia: Findings from the Rush Memory and Aging Project. J Alzheimers Dis. 2019; 67(1):125-135.
    View in: PubMed
    Score: 0.036
  53. Genetic data and cognitively defined late-onset Alzheimer's disease subgroups. Mol Psychiatry. 2020 11; 25(11):2942-2951.
    View in: PubMed
    Score: 0.036
  54. Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease. Acta Neuropathol. 2019 02; 137(2):209-226.
    View in: PubMed
    Score: 0.035
  55. Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol. 2018 12; 136(6):857-872.
    View in: PubMed
    Score: 0.035
  56. Sexual dimorphism in predisposition to Alzheimer's disease. Neurobiol Aging. 2018 10; 70:308-324.
    View in: PubMed
    Score: 0.034
  57. Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition. Acta Neuropathol. 2018 01; 135(1):85-93.
    View in: PubMed
    Score: 0.033
  58. Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. JAMA. 1997 Mar 12; 277(10):822-4.
    View in: PubMed
    Score: 0.032
  59. Risk of incident clinical diagnosis of Alzheimer's disease-type dementia?attributable to pathology-confirmed vascular disease. Alzheimers Dement. 2017 Jun; 13(6):613-623.
    View in: PubMed
    Score: 0.031
  60. Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans. Alzheimers Dement. 2017 02; 13(2):119-129.
    View in: PubMed
    Score: 0.031
  61. Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease. Alzheimers Dement. 2016 06; 12(6):645-53.
    View in: PubMed
    Score: 0.030
  62. Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement. 2016 Mar; 12(3):233-43.
    View in: PubMed
    Score: 0.028
  63. Association of Alzheimer's disease GWAS loci with MRI markers of brain aging. Neurobiol Aging. 2015 Apr; 36(4):1765.e7-1765.e16.
    View in: PubMed
    Score: 0.027
  64. Genome-wide studies of verbal declarative memory in nondemented older people: the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium. Biol Psychiatry. 2015 Apr 15; 77(8):749-63.
    View in: PubMed
    Score: 0.027
  65. Principal components methods for narrow-sense heritability in the analysis of multidimensional longitudinal cognitive phenotypes. Am J Med Genet B Neuropsychiatr Genet. 2013 Oct; 162B(7):770-8.
    View in: PubMed
    Score: 0.024
  66. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron. 2013 Apr 24; 78(2):256-68.
    View in: PubMed
    Score: 0.024
  67. Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory. Neurology. 2012 May 08; 78(19):1464-71.
    View in: PubMed
    Score: 0.023
  68. Genetic variation at CR1 increases risk of cerebral amyloid angiopathy. Neurology. 2012 Jan 31; 78(5):334-41.
    View in: PubMed
    Score: 0.022
  69. A genome-wide scan for common variants affecting the rate of age-related cognitive decline. Neurobiol Aging. 2012 May; 33(5):1017.e1-15.
    View in: PubMed
    Score: 0.022
  70. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet. 2010 Aug 15; 19(16):3295-301.
    View in: PubMed
    Score: 0.020
  71. Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease. Hum Mol Genet. 2008 Apr 01; 17(7):929-35.
    View in: PubMed
    Score: 0.017
  72. Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2007 Dec; 12(4):377-90.
    View in: PubMed
    Score: 0.017
  73. The relation of cigarette smoking to incident Alzheimer's disease in a biracial urban community population. Neuroepidemiology. 2006; 26(3):140-6.
    View in: PubMed
    Score: 0.015
  74. Cognitive activity and incident AD in a population-based sample of older persons. Neurology. 2002 Dec 24; 59(12):1910-4.
    View in: PubMed
    Score: 0.012
  75. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA. 2002 Jun 26; 287(24):3230-7.
    View in: PubMed
    Score: 0.011
  76. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp Neurol. 1999 Aug; 158(2):469-90.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.